EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations
EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations
批准号:
10383202
负责人:
Jeffrey Wigdahl
金额:
$24.76万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2023-11-30
关键词:
AgreementAreaArtificial IntelligenceCaringCellular PhoneClassificationClinicalComputer softwareConsultationsDetectionDevelopmentDevicesDiabetic RetinopathyDiagnosisDiagnosticDiseaseDisease ProgressionDisease regressionDocumentationEnsureEyeFutureGenerationsGoalsGrantImageImage AnalysisJointsLegal patentLesionLettersLicensingMacular degenerationMalariaManufacturer NameMeasuresMethodsOphthalmologistOphthalmoscopesOphthalmoscopyOptometristPaperPathologyPatientsPhasePriceProceduresRecordsRetinaRetinal DiseasesRetinopathy of PrematuritySoftware ToolsSpecialistTechniquesTestingTimeUnited StatesVideo RecordingVisualWorkbaseclinical carecostdesigndiagnostic tooldigitalexperienceimage processingimage registrationimprovedinnovationlenslongitudinal analysisretinal imagingscreeningskillssoftware developmentsuccesstime usetool
中文摘要
总结
英文摘要
Summary
The goal of the proposed project is to develop EyeStar-BIO, a suite of software tools designed to enhance digital
binocular indirect ophthalmoscopy examinations (BIO), one of the most common forms of examination of the
retina. Using BIO, an ophthalmologist can determine the presence of multiple retinal diseases such as diabetic
retinopathy, macular degeneration, and retinopathy of prematurity, among others. The traditional BIO exam
does not produce any visual documentation.
EyeStar-BIO will feature innovative features that are not currently offered as part of digital BIO exams: (1)
automatic image quality assessment, (2) automatic stitching to create a wide-field view of the retina, (3)
longitudinal analysis, and (4) AI-based disease detection. This project has an $800M market potential as BIO
examinations remain one of the most common procedures for ophthalmologists.
The goals of this Phase I project will be accomplished via three specific aims. Aim 1: implement software for
automatic image quality assessment of digital BIO video frames. Aim 2: develop image stitching methods to
generate a wide field view of the retina using the best quality frames in the video. Aim 3: generate images to
track differences in time due to disease progression or regression.
The EyeStar-BIO software will be licensed to manufacturers of digital BIO headsets. Future developments will
include real time implementations of EyeStar-BIO and the ability to diagnose retinal disease using artificial
intelligence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations
-
批准号:10824075
-
项目类别:
-
资助金额:$5.45万
-
财政年份:2022
-
负责人:Jeffrey Wigdahl
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: